This study evaluates the intestinal microbiome and disease activity in patients with spondyloarthropathies receiving immunosuppressive therapy.||Patients will be analysed at two time points in reference to two predefined primary endpoints:||Changes in intestinal microbiome|Response to therapy||The investigators want to evaluate if successful treatment of spondylarthropathy coincide with specific changes in the gut flora.